Table 2.

Glucocorticoid-related complication rates in patients with polymyalgia rheumatica (PMR) and comparators without PMR^*

	Electronic coding, %		No. of events§		Cumulative incidence (95% CI)
Complication	Agreement†	Excess events	Before	After	At 5 years, PMR	At 5 years, non-PMR	HR (95% CI)
Diabetes mellitus	81	18	93/104	38/39	9.5 (5.8–13.1)	11.5 (7.3–15.5)	0.85 (0.54–1.33)
Hypertension	85	13	255/253	42/47	30.4 (20.2–39.2)	33.4 (23.3–42.2)	0.79 (0.52–1.21)
Hyperlipidemia	78	21	276/268	28/30	24.0 (13.6–33.1)	26.6 (16.6–35.4)	1.03 (0.61–1.74)
Cataracts	85	10	203/197	77/66	41.0 (32.1–48.7)	27.3 (19.8–34.2)	1.72 (1.23–2.41)
Hip or femoral neck fracture	99	1	NA	21/25	3.9 (1.8–6.0)	5.1 (2.7–7.4)	0.80 (0.45–1.43)
Symptomatic vertebral fracture	90	3	NA	22/17	3.9 (1.8–6.0)	2.4 (0.7–4.0)	1.27 (0.67–2.39)
Colles fracture	99	3	NA	15/13	2.4 (0.7–4.0)	2.5 (0.8–4.2)	1.11 (0.53–2.33)
Any fracture	90	4	NA	49/49	9.5 (5.8–13.1)	11.5 (7.3–15.5)	0.85 (0.54–1.33)

^*95% CI = 95% confidence interval; HR = hazard ratio; NA = not applicable.

^†Agreement between electronic coding and manual abstraction.

^‡Excess events by coding.

^§PMR incidence/non-PMR index date.